CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology

CML Patients Prescribed Ponatinib Vs Bosutinib #ASH19 @TakedaOncology

ash

2 months
70 Views
Share
Want to watch this again later?
Sign in to add this video to a playlist. Login
Report 0 0
Category:
Description:

Shouryadeep Srivastava, MBBS, PhD of @TakedaOncology discusses CML patients prescribed ponatinib vs bosutinib.

Up Next Autoplay